Beam Therapeutics (BEAM) Return on Invested Capital (2022 - 2025)

Beam Therapeutics (BEAM) has 4 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2025.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.0% (changed 0.0% YoY) and the FY2024 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital grew to 0.0% in Q1 2025 per BEAM's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2024 and bottomed at 0.01% in Q4 2024.
• The 4-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2023, while the deepest fall reached 0 bps in 2023.
• Tracing BEAM's Return on Invested Capital over 4 years: stood at 0.0% in 2022, then soared by 56 bps to 0.0% in 2023, then plunged by 167 bps to 0.01% in 2024, then climbed by 15 bps to 0.0% in 2025.
• Per Business Quant, the three latest BEAM Return on Invested Capital figures stand at 0.0% (Q1 2025), 0.01% (Q4 2024), and 0.0% (Q3 2024).

Peer Comparison